HSPCX | NRGEX | HSPCX / NRGEX | |
Total Expense Ratio | 1.68 | 0.03 | 5,600% |
Annual Report Gross Expense Ratio | 1.70 | 0.69 | 246% |
Fund Existence | 25 years | 4 years | - |
Gain YTD | 7.648 | -3.342 | -229% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.1B | 8.71B | 13% |
Annual Yield % from dividends | 1.66 | 0.54 | 309% |
Returns for 1 year | -2.84 | -9.46 | 30% |
Returns for 3 years | 16.58 | 8.17 | 203% |
Returns for 5 years | -33.31 | N/A | - |
Returns for 10 years | 0.23 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNIX | 75.85 | 0.47 | +0.62% |
Janus Henderson Global Life Sciences I | |||
TICSX | 7.39 | 0.04 | +0.54% |
Touchstone Small Company Instl | |||
GSVPX | 16.76 | 0.05 | +0.30% |
Goldman Sachs Small/Mid Cap Equity P | |||
RLBBX | 38.66 | 0.03 | +0.08% |
American Funds American Balanced R2 | |||
SGQCX | 42.96 | -0.03 | -0.07% |
DWS International Growth C |